Blueprint Medicines Corporation
BPMC
$101.50
$1.161.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 576.24M | 615.49M | 734.17M | 763.60M | 647.90M |
| Total Receivables | 79.80M | 77.61M | 65.81M | 85.06M | 60.05M |
| Inventory | 12.95M | 13.61M | 12.53M | 14.79M | 30.94M |
| Prepaid Expenses | 33.08M | 35.97M | 42.33M | 39.91M | 37.71M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 183.00K | -- |
| Total Current Assets | 702.07M | 742.68M | 854.85M | 903.54M | 776.60M |
|
|
|||||
| Total Current Assets | 702.07M | 742.68M | 854.85M | 903.54M | 776.60M |
| Net Property, Plant & Equipment | 97.66M | 100.77M | 104.27M | 109.05M | 113.17M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 72.33M | 59.21M | 63.66M | 58.31M | 33.21M |
| Total Assets | 1.20B | 1.18B | 1.20B | 1.20B | 1.04B |
|
|
|||||
| Total Accounts Payable | 800.00K | 6.79M | 4.72M | 4.86M | 4.93M |
| Total Accrued Expenses | 81.71M | 102.27M | 99.71M | 96.26M | 86.51M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 125.45M | 118.91M | 117.95M | 114.66M | 87.15M |
| Total Finance Division Other Current Liabilities | 42.63M | 32.82M | 35.29M | 28.02M | 28.01M |
| Total Other Current Liabilities | 42.63M | 32.82M | 35.29M | 28.02M | 28.01M |
| Total Current Liabilities | 250.58M | 260.80M | 257.66M | 243.80M | 206.60M |
|
|
|||||
| Total Current Liabilities | 250.58M | 260.80M | 257.66M | 243.80M | 206.60M |
| Long-Term Debt | 522.66M | 536.58M | 542.84M | 550.45M | 432.30M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 65.22M | 68.79M | 71.92M | 75.24M | 78.49M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 15.01M | 14.99M | 14.08M | 13.83M | 10.40M |
| Total Liabilities | 853.47M | 881.15M | 886.50M | 883.32M | 727.79M |
|
|
|||||
| Common Stock & APIC | 2.75B | 2.71B | 2.67B | 2.62B | 2.57B |
| Retained Earnings | -2.41B | -2.41B | -2.36B | -2.30B | -2.25B |
| Treasury Stock & Other | -3.24M | -3.55M | -1.07M | -3.89M | -3.85M |
| Total Common Equity | 342.13M | 298.67M | 313.15M | 320.24M | 310.69M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 342.13M | 298.67M | 313.15M | 320.24M | 310.69M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 342.13M | 298.67M | 313.15M | 320.24M | 310.69M |
|
|
|||||